Article Text

other Versions

PDF
Pilot randomised controlled trail of occupational therapy to optimise independence in Parkinson’s disease: The PD OT trial
  1. Carl E Clarke (c.e.clarke{at}bham.ac.uk)
  1. University of Birmingham, United Kingdom
    1. Alexander Furmston (a.t.furmston{at}bham.ac.uk)
    1. University of Birmingham, United Kingdom
      1. Eric Morgan (eric.morgan{at}swbh.nhs.uk)
      1. Sandwell and West Birmingham Hospitals NHS Trust, United Kingdom
        1. Smitaa Patel (s.patel{at}bham.ac.uk)
        1. University of Birmingham, United Kingdom
          1. Cath Sackley (c.m.sackley{at}bham.ac.uk)
          1. University of Birmingham, United Kingdom
            1. M F Walker (marion.walker{at}nottingham.ac.uk)
            1. Nottingham City Hospital, United Kingdom
              1. Stirling Bryan (s.bryan{at}bham.ac.uk)
              1. University of Birmingham, United Kingdom
                1. Keith Wheatley (k.wheatley{at}bham.ac.uk)
                1. University of Birmingham, United Kingdom

                  Abstract

                  Objective: To perform a pilot trial of occupational therapy (OT) to optimise functional independence in Parkinson's disease (PD) to assess accrual/withdrawal rates, acceptability, outcome measures, and inform sample size calculation.

                  Method: Non-demented patients with idiopathic PD and difficulties with activities of daily living (ADL) were recruited provided they had not received OT in the last 2 years and/or physiotherapy in the last year. Patients were randomised to immediate OT or OT after completion of the trial. Patients randomised to OT were assessed at home by an experienced therapist then received 6 home treatment sessions over 2 months. Interventions were targeted at functional independence and mobility goals. Outcome measures were: Nottingham Extended Activity of Daily Living Scale, Rivermead Mobility Index, Unified Parkinson's Disease Rating Scale ADL scale, Parkinson's Disease Questionnaire 39, EuroQol-EQ-5D, Hospital Anxiety and Depression Scale, and health economics analysis.

                  Results: 39 patients (25 male; mean age 73 years) were recruited from four centres over 16 months. The mean difference in NEADL at 8 months was 3.5 (95%CI -3.2; 10.2). The mean difference in PDQ-39 Summary Score was 3.8 (95% CI -4.94; 12.6). There were strong correlations between the PDQ-39 and other outcomes. The intervention was acceptable to patients, with a low withdrawal rate and good questionnaire completion.

                  Conclusion: Randomisation to a trial of OT in PD is feasible. NEADL and PDQ-39 are relevant outcomes and provided data to inform sample size for an adequately powered randomised trial for which there is pressing need.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.